SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-024111
Filing Date
2024-06-17
Accepted
2024-06-17 16:15:32
Documents
14
Period of Report
2024-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 53565
  Complete submission text file 0001493152-24-024111.txt   276990

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE harrowcom-20240614.xsd EX-101.SCH 3979
3 XBRL DEFINITION FILE harrowcom-20240614_def.xml EX-101.DEF 27027
4 XBRL LABEL FILE harrowcom-20240614_lab.xml EX-101.LAB 37273
5 XBRL PRESENTATION FILE harrowcom-20240614_pre.xml EX-101.PRE 25647
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6677
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 241048405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)